Table 3. Maximum doping substance intake and doping control risk

Supplement	Weight maximum daily dose	Compound (class)	Contamination calculation	Positive doping control threshold	Estimated potential risk
B5	1.5 g	higenamine	1.5 µg	10 µg	NO 2017
F1	15 g	BMPEA †  NBDMPEA †  Oxilofrine †	0.39 g 15 mg 0.17 g	50 µg 50 µg 50 µg	YES YES YES
F3	20 g	BMPEA †  NBDMPEA †  Oxilofrine †	0.98 g 0.48 g 0.80 g	50 µg 50 µg 50 µg	YES YES YES
G2	3.0 g	Endogenous AAS (1) higenamine oxilofrine testosterone	3.0 µg 3.0 µg 3.0 µg 3.0 µg	1 mg 10 µg 50 µg 1 mg	NO NO 2017 NO NO
G3	3.0 g	cathine ephedrine methylephedrine oxilofrine †  strychnine testosterone	3.0 µg 3.0 µg 3.0 µg 0.17 g 3.0 µg 3.0 µg	5 mg 10 mg 10 mg 50 µg 50 µg 1 mg	NO NO NO YES NO NO
H23	4.8 g	Endogenous AAS (6) ephedrine higenamine	29 µg 4.8 µg 4.8 µg	1 mg 10 mg 50 µg	NO NO NO 2017
O2	4.8 g	higenamine	4.8 µg	10 µg	NO 2017
Q1	89 g	DMBA oxilofrine	89 µg 89 µg	50 µg 50 µg	YES YES

† = high level finding, 2017 = before September 2017 this product was estimated to potentially cause a positive doping test, 3=this product contained 3 components which were tested separately